Skip to main content

Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM): A treatment trial in patients with established natural history data

Publication ,  Conference
Dalakas, M; Rakocevic, G; McElroy, B; Salajegheh, M; Love, MH; Shrader, J; Levy, E; Kirk, AD
Published in: NEUROLOGY
March 20, 2007

Duke Scholars

Published In

NEUROLOGY

ISSN

0028-3878

Publication Date

March 20, 2007

Volume

68

Issue

12

Start / End Page

A361 / A361

Location

Boston, MA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

59th Annual Meeting of the American-Academy-of-Neurology

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dalakas, M., Rakocevic, G., McElroy, B., Salajegheh, M., Love, M. H., Shrader, J., … Kirk, A. D. (2007). Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM): A treatment trial in patients with established natural history data. In NEUROLOGY (Vol. 68, pp. A361–A361). Boston, MA: LIPPINCOTT WILLIAMS & WILKINS.
Dalakas, Marinos, Goran Rakocevic, Beverly McElroy, Mohammad Salajegheh, Michael H. Love, Joseph Shrader, Ellen Levy, and Allan D. Kirk. “Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM): A treatment trial in patients with established natural history data.” In NEUROLOGY, 68:A361–A361. LIPPINCOTT WILLIAMS & WILKINS, 2007.
Dalakas M, Rakocevic G, McElroy B, Salajegheh M, Love MH, Shrader J, et al. Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM): A treatment trial in patients with established natural history data. In: NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. A361–A361.
Dalakas, Marinos, et al. “Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM): A treatment trial in patients with established natural history data.” NEUROLOGY, vol. 68, no. 12, LIPPINCOTT WILLIAMS & WILKINS, 2007, pp. A361–A361.
Dalakas M, Rakocevic G, McElroy B, Salajegheh M, Love MH, Shrader J, Levy E, Kirk AD. Alemtuzumab (CAMPATH 1-H) therapy in sporadic inclusion body myositis (sIBM): A treatment trial in patients with established natural history data. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. A361–A361.

Published In

NEUROLOGY

ISSN

0028-3878

Publication Date

March 20, 2007

Volume

68

Issue

12

Start / End Page

A361 / A361

Location

Boston, MA

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

59th Annual Meeting of the American-Academy-of-Neurology

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1702 Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences